DBTX logo

Decibel Therapeutics (DBTX) Cash From Investing

Annual CFI

$55.10 M
+$156.09 M+154.55%

December 31, 2022


Summary


Performance

DBTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherDBTXcash flowmetrics:

Quarterly CFI

$11.77 M
-$8.54 M-42.06%

June 30, 2023


Summary


Performance

DBTX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherDBTXcash flowmetrics:

TTM CFI

$31.74 M
-$47.29 M-59.84%

June 30, 2023


Summary


Performance

DBTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherDBTXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DBTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+154.6%-80.1%-57.8%
3 y3 years-3.9%+518.0%+133.4%
5 y5 years+177.2%--

DBTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-283.3%-80.1%-151.0%-59.8%-418.2%
5 y5-year-3.9%-283.3%-80.1%-1055.2%-59.8%-564.3%
alltimeall time-3.9%-283.3%-80.1%-1055.2%-59.8%-564.3%

Decibel Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2023
-
$11.77 M(-42.1%)
$31.74 M(-59.8%)
Mar 2023
-
$20.32 M(+259.7%)
$79.03 M(+43.4%)
Dec 2022
$55.10 M(-154.6%)
$5.65 M(-194.2%)
$55.10 M(+25.5%)
Sep 2022
-
-$6.00 M(-110.2%)
$43.88 M(-41.6%)
Jun 2022
-
$59.06 M(-1733.4%)
$75.20 M(+860.2%)
Mar 2022
-
-$3.62 M(-35.0%)
$7.83 M(-107.8%)
Dec 2021
-$101.00 M
-$5.56 M(-122.0%)
-$101.00 M(-17.3%)
Sep 2021
-
$25.32 M(-404.7%)
-$122.13 M(-17.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$8.31 M(-92.6%)
-$147.37 M(+7.4%)
Mar 2021
-
-$112.44 M(+321.2%)
-$137.15 M(+953.9%)
Dec 2020
-$13.01 M(-122.7%)
-$26.69 M(<-9900.0%)
-$13.01 M(-195.1%)
Sep 2020
-
$82.00 K(-95.7%)
$13.68 M(+0.6%)
Jun 2020
-
$1.91 M(-83.7%)
$13.60 M(+16.3%)
Mar 2020
-
$11.69 M
$11.69 M
Dec 2019
$57.34 M(-180.3%)
-
-
Dec 2018
-$71.39 M
-
-

FAQ

  • What is Decibel Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Decibel Therapeutics?
  • What is Decibel Therapeutics annual CFI year-on-year change?
  • What is Decibel Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Decibel Therapeutics?
  • What is Decibel Therapeutics quarterly CFI year-on-year change?
  • What is Decibel Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Decibel Therapeutics?
  • What is Decibel Therapeutics TTM CFI year-on-year change?

What is Decibel Therapeutics annual cash flow from investing activities?

The current annual CFI of DBTX is $55.10 M

What is the all time high annual CFI for Decibel Therapeutics?

Decibel Therapeutics all-time high annual cash flow from investing activities is $57.34 M

What is Decibel Therapeutics annual CFI year-on-year change?

Over the past year, DBTX annual cash flow from investing activities has changed by +$156.09 M (+154.55%)

What is Decibel Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of DBTX is $11.77 M

What is the all time high quarterly CFI for Decibel Therapeutics?

Decibel Therapeutics all-time high quarterly cash flow from investing activities is $59.06 M

What is Decibel Therapeutics quarterly CFI year-on-year change?

Over the past year, DBTX quarterly cash flow from investing activities has changed by -$47.29 M (-80.07%)

What is Decibel Therapeutics TTM cash flow from investing activities?

The current TTM CFI of DBTX is $31.74 M

What is the all time high TTM CFI for Decibel Therapeutics?

Decibel Therapeutics all-time high TTM cash flow from investing activities is $79.03 M

What is Decibel Therapeutics TTM CFI year-on-year change?

Over the past year, DBTX TTM cash flow from investing activities has changed by -$43.47 M (-57.80%)